Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AX-8 in chronic refractory cough with upper airway symptoms
2016-004803-30Phase 2Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jan 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ax-8 in refractory chronic cough (RCC) (3 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Change from baseline in cough frequency over 8 hours. Started Jan 2017; status: terminated.
02
Drugs
ax-8
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on 2016-004803-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004803-30.